Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients

Many patients have advanced esophageal cancer at diagnosis. However, the most optimal treatment has not been identified. Therefore, we evaluated a weekly regimen of carboplatin (area under the curve (AUC)) of 4 and paclitaxel at 100 mg/m(2) as an induction or palliative treatment. All patients with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: de Man, Femke M., van Eerden, Ruben A.G., Oomen-de Hoop, Esther, Veraart, Joris N., van Doorn, Nadia, van Doorn, Leni, van der Gaast, Ate, Mathijssen, Ron H.J.
Format: Artigo
Langue:Inglês
Publié: MDPI 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627268/
https://ncbi.nlm.nih.gov/pubmed/31200588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060826
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires